Variant-specific drug responses in FH: an ex vivo pilot study

13 June 2026 (12:08 - 12:11)

Organised by:

About the speaker

Mr Rafael Graca

National Health Institute Doutor Ricardo Jorge, IP, Lisbon (Portugal)

9 More presentations in this session

Presentation thumbnail

Investigating oxpl-mediated vascular inflammation in humanized Lp(a) transgenic mice: a preclinical study toward novel therapeutic strategies

Mr V. Antoniou (Athens, GR)

Presentation thumbnail

Transcriptomic analysis of mRNA in mouse model of chronic cigarette smoke-induced endothelial dysfunction treated with recombinant angiotensin-converting enzyme 2

Mr H. Hermawan (Surabaya, ID)

Presentation thumbnail

Ruxolitinib attenuates cardio-renal inflammation via JAK-STAT and CaMKII signaling in hypertension

Ms M. Kiessling (Graz, AT)

Presentation thumbnail

Role and mechanisms of the J1 gene in pulmonary arterial hypertension

Miss J. Ma (Guangzhou, CN)

Presentation thumbnail

Unexpected cardioprotection in doxorubicin-treated mice during sepsis: Dennd4a-Rab10 axis as a potential mediator

Miss K. Markandran (Singapore, SG)

Access the full session

Session thumbnail

Module B: Mentoring & how-to sessions - Poster rapid fire session 4

The Event

Event poster

Basic Science Course 2026

13 June 2026 12:08 CET

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources